PETX
Aratana Therapeutics Inc.
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
Actual EPS |
---|
Consensus EPS |
Estimated EPS |
Number of Estimates |
EPS Surprise |
Stats
Summary
Aratana Therapeutics Inc is a pet therapeutics company. Its main activity is the licensing, developing, and commercializing of innovative biopharmaceutical products for companion animals.
Market Cap: 208 Million
Primary Exchange: NASDAQ Global Market
Website: http://www.aratana.com
Shares Outstanding: 43 Million
Float: 41.4 Million
Dividend: 0.0 (0.0%)
Beta: 3.424745
Sector: Healthcare
Industry: Biotechnology
Ethical Flags
Longest drawdown: 1495 trading days
From: 2013-10-16 To: 2019-06-07
Lowest Point:
Aratana Therapeutics Granted FDA Approval of NOCITA® (bupivacaine liposome injectable suspension) 10 mL Vial
via: PR Newswire at 2019-06-11 12:05:00:000
LEAWOOD, Kan. , June 11, 2019 /PRNewswire/ --Aratana Therapeutics, Inc. (Nasdaq: PETX), a pet therapeutics company focused on the development and commercialization of innovative therapeutics for dogs and cats, today announced the U.S. Food and Drug Administration's Center for Veteri… read more...
Aratana Therapeutics Granted FDA Approval of NOCITA® (bupivacaine liposome injectable suspension) 10 mL Vial
via: PR Newswire at 2019-06-11 12:05:00:000
LEAWOOD, Kan. , June 11, 2019 /PRNewswire/ --Aratana Therapeutics, Inc. (Nasdaq: PETX), a pet therapeutics company focused on the development and commercialization of innovative therapeutics for dogs and cats, today announced the U.S. Food and Drug Administration's Center for Veteri… read more...
Aratana Therapeutics Granted FDA Approval of NOCITA® (bupivacaine liposome injectable suspension) 10 mL Vial
via: PR Newswire at 2019-06-11 12:05:00:000
LEAWOOD, Kan. , June 11, 2019 /PRNewswire/ --Aratana Therapeutics, Inc. (Nasdaq: PETX), a pet therapeutics company focused on the development and commercialization of innovative therapeutics for dogs and cats, today announced the U.S. Food and Drug Administration's Center for Veteri… read more...
Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
---|
Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
---|